Intersect Capital’s Usana Health Sciences USNA Stock Holding History

Intersect Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$317K	Buy	+4,383	New	+$326K	0.1%	222
2022 Q1	–	Sell	-2,211	Closed	-$224K	–	469
2021 Q4	$224K	Buy	+2,211	New	+$221K	0.04%	384
2021 Q3	–	Sell	-1,957	Closed	-$200K	–	417
2021 Q2	$200K	Buy	+1,957	New	+$196K	0.04%	356

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Intersect Capital's USNA Position: Q2 2022 in Review

Intersect Capital opened a new position in Usana Health Sciences (USNA) in Q2 2022: 4,383 shares worth $317K. The stake represents 0.1% of the portfolio and ranks #222 among its holdings. This is a return to the name: Intersect Capital previously reported a position in USNA as recently as Q4 2021.

Intersect Capital first reported a position in USNA in Q2 2021 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold USNA as of Q2 2022.

Intersect Capital held 4,383 shares of Usana Health Sciences worth $317K as of Q2 2022.
Usana Health Sciences was a new Intersect Capital position in Q2 2022.
Usana Health Sciences made up 0.1% of Intersect Capital's portfolio in Q2 2022, its #222 holding.
Intersect Capital first reported a position in Usana Health Sciences in Q2 2021 and has held it in 3 quarters since.
182 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.